Sustained Release Travoprost: Phase IIb started

Ocular Therapeutix began a double-blind, U.S. Phase IIb

Read the full 87 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE